Levothyroxine Therapy Achieves Physiological FT3/FT4 Ratios at Higher than Normal TSH Levels: A Novel Justification for T3 Supplementation?

MLA

Strich, David, et al. “Levothyroxine Therapy Achieves Physiological FT3/FT4 Ratios at Higher than Normal TSH Levels: A Novel Justification for T3 Supplementation?” Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme, vol. 50, no. 11, Nov. 2018, pp. 827–31. EBSCOhost, https://doi.org/10.1055/a-0751-0498.

APA

Strich, D., Chay, C., Karavani, G., Edri, S., & Gillis, D. (2018). Levothyroxine Therapy Achieves Physiological FT3/FT4 Ratios at Higher than Normal TSH Levels: A Novel Justification for T3 Supplementation? Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme, 50(11), 827–831. https://doi.org/10.1055/a-0751-0498

Chicago

Strich, David, Cherut Chay, Gilad Karavani, Shalom Edri, and David Gillis. 2018. “Levothyroxine Therapy Achieves Physiological FT3/FT4 Ratios at Higher than Normal TSH Levels: A Novel Justification for T3 Supplementation?” Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme 50 (11): 827–31. doi:10.1055/a-0751-0498.